Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
-828K
-
Total reported value, excl. options
-
$633M
-
Value change
-
-$6.21M
-
Put/Call ratio
-
0.32
-
Number of buys
-
63
-
Number of sells
-
-60
-
Price
-
$16.30
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2017
152 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2017.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 58.9M outstanding shares and own 65.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.47M shares), Palo Alto Investors, LLC (4.2M shares), VANGUARD GROUP INC (2.68M shares), GREAT POINT PARTNERS LLC (2.23M shares), ARMISTICE CAPITAL, LLC (2.06M shares), Point72 Asset Management, L.P. (1.94M shares), MACQUARIE GROUP LTD (1.7M shares), STATE STREET CORP (1.62M shares), FMR LLC (1.6M shares), and MORGAN STANLEY (1.18M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.